At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Investors
 



Home >> Investor Relations >> Corporate Governance >> Insider Transactions

Insider Transactions

Date Name Title Type Sorted Ascending Shares Traded Price Range
Feb 1, 2008 licholai gregory p Officer Sell 10,000 9.90
Aug 18, 2008 licholai gregory p Officer Sell 1,401 15.11
Jul 22, 2008 licholai gregory p Officer Sell 15,000 15.00
Jul 15, 2008 licholai gregory p Officer Sell 15,000 13.00
Jun 5, 2007 new enterprise associates 11 lp Beneficial Owner (10% or more) Sell 6,408 15.00
Jun 5, 2007 newhall charles w iii Beneficial Owner (10% or more) Sell 6,408 15.00
Feb 1, 2008 palling david Officer Sell 3,000 10.00
Feb 28, 2008 palling david Officer Sell 2,500 10.46 - 10.55
Sep 8, 2008 palling david Officer Sell 3,000 14.83
Jun 5, 2007 perry mark w Beneficial Owner (10% or more) Sell 6,408 15.00
Jun 5, 2007 prospect venture partners ii lp Beneficial Owner (10% or more) Sell 6,427 15.00
Aug 15, 2008 sblendorio glenn Director Sell 1,400 16.74
May 24, 2011 valenzano ken Officer Sell 2,250 7.50
Aug 14, 2008 weinhoff gregory m Director Sell 50,000 17.00
May 30, 2007 Chl Medical Partners ii side fund, L.p. Beneficial Owner (10% or more) Statement of Ownership 0 n/a
May 30, 2007 Chl Medical Partners ii side fund, L.p. Beneficial Owner (10% or more) Statement of Ownership 0 n/a
May 30, 2007 Chl Medical Partners ii, L.p. Beneficial Owner (10% or more) Statement of Ownership 0 n/a
May 30, 2007 Chl Medical Partners ii, L.p. Beneficial Owner (10% or more) Statement of Ownership 0 n/a
May 30, 2007 crowley john f Officer Statement of Ownership 0 n/a
May 30, 2007 dentzer james e Officer Statement of Ownership 0 n/a
Showing 361-380 of 392 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Amicus Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.


Copyright © 2012 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy